about
Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson's diseaseTransgenic rodent models of Parkinson’s diseaseGenetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation updatePINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagyMutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stabilityIdentification of new kinase clusters required for neurite outgrowth and retraction by a loss-of-function RNA interference screenBiochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1)PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.GBA server: EST-based digital gene expression profilingUbiquitin phosphorylation in Parkinson's disease: Implications for pathogenesis and treatmentCeramide induced mitophagy and tumor suppressionImpaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient miceThe PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons.Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.Antioxidants protect PINK1-dependent dopaminergic neurons in DrosophilaAnalysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonismPINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease.Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1.Huntingtin protein is essential for mitochondrial metabolism, bioenergetics and structure in murine embryonic stem cellsUnveiling clusters of RNA transcript pairs associated with markers of Alzheimer's disease progression.Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.The genetics of Parkinson disease.Transgenic animal models of neurodegeneration based on human genetic studies.Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing.Unfolded protein stress in the endoplasmic reticulum and mitochondria: a role in neurodegenerationPopulation genetic approaches to neurological disease: Parkinson's disease as an example.PINK1 mutation heterozygosity and the risk of Parkinson's disease.Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutationsDifferential submitochondrial localization of PINK1 as a molecular switch for mediating distinct mitochondrial signaling pathways.Recessive Parkinson's disease.Biology of mitochondria in neurodegenerative diseases.Parkinson's disease: the genetics of a heterogeneous disorder.Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease.Characterization of PINK1 (PTEN-induced putative kinase 1) mutations associated with Parkinson disease in mammalian cells and DrosophilaCongenital disease SNPs target lineage specific structural elements in protein kinasesTransgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration.Genetics of Parkinson disease.Progress in the pathogenesis and genetics of Parkinson's disease.
P2860
Q21245635-80B790CC-8972-4C3F-832F-72E773CB4C2FQ22252835-4127B247-B3A7-4D4C-B3EA-0479B24B297FQ22252904-DFCC0515-C239-4F94-9026-AC2E0F37F78FQ24299149-F1A3818B-A71D-43F5-99FB-398C325E3566Q24299939-B7F50A82-FD85-41B7-9B26-83FD3D3748B6Q24300657-E9997B84-42C8-462E-81E1-D410C3FE4DFFQ24307730-38521569-5382-43DF-AF82-0A938205254FQ24312106-7DA24222-E18E-4D96-A323-56DBCCDD5FF8Q24339508-491B4F83-0C09-4924-8828-2BAE0E3258A5Q24813326-36FB6C80-A7DE-4D32-A6C0-8FDFC85768C2Q26770342-EF1C5775-E6A4-46D8-A72D-5B0ED478134CQ28384389-34A6C7C0-8155-4DF8-8275-605DD371B64FQ28513036-FD3A1BE2-9BFD-4140-9941-F1024E202FCAQ30273994-67F0827D-2DB3-4126-833A-B8A731D30690Q30573776-6CE835D1-CCE5-47BD-9E3C-3F5FC797451DQ33255660-1F4C7254-5094-439B-9A56-9D19E2232DD4Q33315729-C1F5ED8C-B8C8-44DC-B552-853F256BF8CBQ33393439-6B954DC4-346A-4EDD-8CCB-48D92A3107ADQ33412371-6F2C8ECE-971D-40A0-9689-3D9695AFD237Q33799876-44954464-433B-4805-A795-96261305E74BQ33945927-9DE6259A-7F99-4722-BFB8-04F749D3F886Q34429308-4338F4CB-69AC-48BF-B087-E12878F48A84Q34502221-376C6D09-3B18-4B02-94CB-C2749C1E28FCQ34604083-ECEFFDBF-E5AB-4E79-BDE6-5FACF82D6086Q34890228-92405FC0-6B91-4251-9108-E39979B49D45Q35126377-1417F891-5A86-4C51-8B86-3E70B86877DFQ35911798-D1C02EC8-DD70-486C-ACA4-78F39386A00DQ36226918-20BD8FC6-AA1D-4220-8C92-416A1CEEDFA3Q36227281-2A5912CF-EA2F-4F82-8BD8-C2829A470BBCQ36227376-5BB2957F-BEB5-4686-A0E5-DFA54391C2A1Q36385121-FED51B8E-D153-4923-8A6D-05A6BA5F9F8BQ36449306-C0598BDB-4B80-44D6-AF96-D81722F305B7Q36488715-E5357952-9DF5-4E04-A2EA-CB48346A5D3CQ36516918-A28BEB52-CADA-4690-931D-096DA8E59E63Q36595645-08AA79D4-2069-4006-9507-15E84805B56EQ36636038-64EF4A84-A5DA-4A60-81B5-0A35ADF1A2EDQ36752464-170C9098-6ABD-47F1-A110-8EB0525B8076Q36861432-CC47C886-CB7E-4398-B82E-DCF52E3C9F2AQ37037053-15A0FA22-6F0F-4FCF-9454-CF7A49DF2F09Q37143657-A2B27941-B08C-4B7C-B71B-29F0364124AA
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Novel PINK1 mutations in early-onset parkinsonism.
@ast
Novel PINK1 mutations in early-onset parkinsonism.
@en
Novel PINK1 mutations in early-onset parkinsonism.
@nl
type
label
Novel PINK1 mutations in early-onset parkinsonism.
@ast
Novel PINK1 mutations in early-onset parkinsonism.
@en
Novel PINK1 mutations in early-onset parkinsonism.
@nl
prefLabel
Novel PINK1 mutations in early-onset parkinsonism.
@ast
Novel PINK1 mutations in early-onset parkinsonism.
@en
Novel PINK1 mutations in early-onset parkinsonism.
@nl
P2093
P356
P1433
P1476
Novel PINK1 mutations in early-onset parkinsonism.
@en
P2093
Arlene R Ng
Chin-Song Lu
Hiroyo Yoshino
Hiroyuki Tomiyama
Kenichi Sato
Masato Asahina
Nobuyoshi Shimizu
Raymond L Rosales
Sharon Hassin-Baer
Shuichi Asakawa
P304
P356
10.1002/ANA.20251
P577
2004-09-01T00:00:00Z